New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2013
14:33 EDTCLXClorox increasingly confident in 2H13 outlook
On the company's Q2 earnings conference call, Clorox (CLX) CEO Don Knauss said based on the 5% sales and 10% EPS growth in 1H13, continued growth in all categories, and a pipeline of second half product innovation, he felt "more optimistic about the full year outlook." For FY13, Clorox anticipates free cash flow of 9%-10% of sales. The company continues to expect EBIT margin will increase by 25-50 bps for FY13, reflecting strong cost savings and the benefit of price increases. Commodity costs are estimated to be about flat versus the prior year. Capital expenditures are expected to be approximately $200M-$210M. Management did note that its updated FY13 outlook reflects a range of 5c-10c of diluted earnings per share impact from an expected currency devaluation in Venezuela and the continued difficulty of taking pricing in that country. Overall, management is increasingly bullish on the company's prospects for the second half of FY13.
News For CLX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 15, 2015
08:36 EDTCLXClorox chairman Donald Knauss to retire July 1
Clorox announced that executive chairman Donald Knauss has decided to retire from the company and the board. The company and the board have accepted his resignation, effective July 1. The board of directors also has appointed George Harad as independent chair of the board, effective July 1. Matschullat will become chair of the nominating and governance committee, effective immediately, and Jeffrey Noddle will become chair of the management development and compensation committee, effective July 1.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use